Pricing Log in Create free account

Atea Pharmaceuticals, Inc. (AVIR) vs C4 Therapeutics, Inc. (CCCC)

Atea Pharmaceuticals, Inc. and C4 Therapeutics, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and C4 Therapeutics, Inc. are of similar size ($363.3M and $342.0M). Atea Pharmaceuticals, Inc. has the higher net margin (0.00% vs −289.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Atea Pharmaceuticals, Inc. leads on 7 and C4 Therapeutics, Inc. on 7.

Valuation

Metric AVIR CCCC Biotechnology median
P/E n/m n/m 8.50
P/S 0.98 10.33 9.71
P/B 1.69 1.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.36 3.63 9.21
Earnings yield (48.15%) (36.10%) (33.15%)
Free cash flow yield (159.02%) (23.59%) (25.50%)

Profitability

Metric AVIR CCCC Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (318.97%) 0.00%
Net margin 0.00% (289.44%) 0.00%
Free cash flow margin 0.00% (243.71%) 0.00%
Return on equity (58.14%) (48.14%) (56.36%)
Return on assets (52.99%) (30.92%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVIR CCCC Biotechnology median
Revenue growth (TTM) — 2.33% 6.02%
EPS growth (last fiscal year) 3.00% 16.45% 30.26%
Revenue growth, 5-year CAGR — 1.61% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVIR CCCC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.13 5.45 4.72
Net debt to EBITDA 1.63 2.14 0.96

Dividend

Metric AVIR CCCC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AVIR CCCC Biotechnology median
Market cap 363.33m 342.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack